CA Stock MarketDetailed Quotes

GUD Knight Therapeutics Inc

Watchlist
  • 5.290
  • -0.010-0.19%
15min DelayMarket Closed Nov 22 16:00 ET
533.25MMarket Cap-18241P/E (TTM)

Knight Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:CAD
2023/FY
Stock NameRevenueRatio
Development, acquisition, in-licensing, out-licensing, marketing and distribution of innovative328.2M100.00%
Product

No Data

Industry

No Data

Region Currency:CAD
2023/FY
Stock NameRevenueRatio
Brazil168.22M51.25%
Rest of Latin America (LATAM)55.1M16.79%
Colombia44.63M13.60%
Argentina24.1M7.34%
Canada19.67M5.99%
Other16.48M5.02%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data